Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.1B | 14.4B | 20.6B | 15.2B |
Cost of revenue | 10.7B | 9.5B | 13.1B | 8.8B |
Gross profit | 6.4B | 4.9B | 7.5B | 6.4B |
Operating expense | ||||
Research & development | — | 858.8M | 827.5M | 898.9M |
Selling general and admin | 3.0B | 648.1M | 606.5M | 631.2M |
Other operating expenses | — | 118.9M | 10.8M | 102.6M |
Operating income | 6.4B | 1.3B | 4.3B | 3.0B |
Non operating interest income | ||||
Income | — | 1.2B | 455.8M | 963.3M |
Expense | — | 4.5M | 4.6M | -2.9M |
Other income expense | — | — | — | — |
Pretax income | 4.6B | 4.3B | 3.1B | 6.1B |
Tax provision | 828.9M | 1.5B | -93.8M | 1.1B |
Net income | 3.8B | 2.8B | 3.2B | 5.0B |
Basic EPS | 405.2 | — | 315 | 504 |
Diluted EPS | 405.2 | — | 315 | 504 |
Basic average shares | — | — | 9.9M | 10.0M |
Diluted average shares | — | — | 9.9M | 10.0M |
EBITDA | 6.4B | 4.7B | 5.8B | 6.4B |
Net income from continuing op. | — | 470.6M | 3.1B | 6.1B |
Minority interests | -19.7M | 177.3M | -34.8M | -3.3M |
Preferred stock dividends | — | — | — | — |